Grail

Download PDF Illumina, Inc. (ILMN: NASDAQ) – market cap 01/10/2020: $45.5bn Grail – privately held   Introduction On September 21st, 2020, the biotech pioneer Illumina agreed to buy the cancer screening start-up Grail in a $8bn deal. Illumina will pay $3.5bn in cash and $4.5bn in common stock to finance Read more…